Olema Pharmaceuticals Ownership | Who Owns Olema Pharmaceuticals?
Olema Pharmaceuticals Ownership Summary
Olema Pharmaceuticals is owned by 45.55% institutional investors, 3.32% insiders, and 51.13% retail investors. Bain capital life sciences investors is the largest institutional shareholder, holding 11.65% of OLMA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.89% of its assets in Olema Pharmaceuticals shares.
OLMA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Olema Pharmaceuticals | 45.55% | 3.32% | 51.13% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bain capital life sciences investors | 6.84M | 11.65% | $25.73M |
| Paradigm biocapital advisors lp | 6.74M | 11.48% | $25.35M |
| Bvf inc/il | 5.30M | 9.02% | $19.91M |
| Blackrock | 4.00M | 7.11% | $43.27M |
| Blackrock funding, inc. /de | 3.79M | 6.62% | $22.09M |
| Point72 asset management | 3.67M | 6.41% | $21.40M |
| Deep track capital, lp | 3.44M | 5.86% | $12.95M |
| Logos global management lp | 3.21M | 5.60% | $18.71M |
| Bioimpact capital | 2.93M | 4.99% | $11.02M |
| Vanguard group | 2.69M | 4.69% | $15.65M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bain capital life sciences investors | 6.84M | 3.81% | $25.73M |
| Logos global management lp | 3.21M | 2.19% | $18.71M |
| Bioimpact capital | 2.93M | 1.89% | $11.02M |
| Ghost tree capital | 550.00K | 1.86% | $5.95M |
| Paradigm biocapital advisors lp | 6.74M | 1.16% | $25.35M |
| Vivo capital | 1.51M | 0.98% | $8.78M |
| Bvf inc/il | 5.30M | 0.81% | $19.91M |
| Highvista strategies | 212.19K | 0.46% | $1.24M |
| Deep track capital, lp | 3.44M | 0.42% | $12.95M |
| Boxer capital | 650.00K | 0.37% | $7.03M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 4.00M | 0.00% | 782.96K |
| Boxer capital | 650.00K | 0.37% | 650.00K |
| Wellington management group llp | 1.53M | 0.00% | 522.80K |
| Ubs group | 560.51K | 0.00% | 482.96K |
| Schroder investment management group | 533.11K | 0.00% | 450.92K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avoro capital advisors | - | - | -1.65M |
| State street | 1.95M | 0.00% | -1.23M |
| Great point partners | - | - | -1.00M |
| Polar capital | - | - | -1.00M |
| Victory capital management | 93.10K | 0.00% | -758.41K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Boxer capital | 650.00K | 0.37% | 650.00K | $7.03M |
| Pier capital | 272.37K | 0.23% | 272.37K | $1.59M |
| Bnp paribas arbitrage, snc | 193.75K | 0.00% | 193.75K | $1.13M |
| Walleye capital | 67.01K | 0.00% | 67.01K | $390.65K |
| Pitcairn | 27.01K | 0.02% | 27.01K | $292.28K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Abich financial wealth management | -10.00 |
| Lindbrook capital | -41.00 |
| Srs capital advisors | -65.00 |
| Nisa investment advisors | -86.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 10 | -93.71% | 26,757,361 | -62.46% | 45 | 0.29% | 5 | -94.57% | 4 | -89.19% |
| Dec 31, 2024 | 158 | 17.04% | 71,277,656 | 21.51% | 124 | 1.19% | 91 | 35.82% | 38 | -7.32% |
| Sep 30, 2024 | 135 | 4.65% | 58,661,342 | 1.34% | 102 | 0.97% | 68 | -16.05% | 41 | 28.13% |
| Jun 30, 2024 | 129 | - | 57,887,400 | 3.20% | 102 | 1.01% | 81 | 15.71% | 32 | -3.03% |
| Mar 31, 2024 | 129 | 6.61% | 56,092,366 | 8.80% | 100 | 0.78% | 70 | -5.41% | 33 | 50.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.97M | 2.89% | 342.97K |
| Vanguard US Total Market Shares ETF | 1.49M | 2.18% | - |
| Franklin Biotechnology Discv A(acc)USD | 1.32M | 1.93% | - |
| iShares Russell 2000 ETF | 1.04M | 1.52% | 510.00 |
| Candriam Global Equities Oncology | 860.55K | 1.50% | 187.55K |
| Pictet-Biotech P USD | 926.07K | 1.35% | -36.23K |
| Franklin US Small Cap Growth Equity | 893.20K | 1.31% | 893.20K |
| Franklin Small Cap Growth Adv | 893.20K | 1.31% | - |
| Belfius Equities Cure C Cap | 850.45K | 1.24% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 818.20K | 1.20% | 1.89K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 08, 2025 | Bain Capital Life Sciences Investors, LLC | - | Buy | $1.73M |
| Dec 13, 2024 | Graham G. Walmsley | - | Buy | $4.73M |
| Dec 13, 2024 | Graham G. Walmsley | - | Sell | $4.73M |
| Dec 17, 2024 | Graham G. Walmsley | - | Sell | $4.73M |
| Dec 17, 2024 | Graham G. Walmsley | - | Sell | $4.73M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 2 | 17 |
| 2024 Q3 | - | 5 |
| 2024 Q2 | - | 8 |
| 2024 Q1 | - | 5 |
| 2023 Q4 | 4 | 23 |
OLMA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools